Briefs: Alkem Laboratories and Zydus Lifesciences
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
USFDA inspects Zydus Lifesciences’ Ahmedabad SEZ Onco manufacturing plant
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023
The company is addressing these observations
The United States Food and Drug Administration (USFDA) conducted an inspection at Gland Pharma Limited API Facility at JNPC, Visakhapatnam
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
The company will address the observations within a stipulated timeline working with the regulators
MonoFerric, iron isomaltoside 1000 solution for injection/infusion, is a rapid, single dose IV iron developed to reduce the number of infusions
Subscribe To Our Newsletter & Stay Updated